James Oliviero
Chief Executive Officer at CHECKPOINT THERAPEUTICS, INC.
Net worth: 666 488 $ as of 30/04/2024
Profile
James F.
Oliviero is currently the President, Chief Executive Officer & Director at Checkpoint Therapeutics, Inc. He is also an Independent Director at Nuvectis Pharma, Inc. Previously, he served as the Finance Director at ACCESS Oncology, Inc. from 1999 to 2003.
He then worked as the Chief Financial Officer & Treasurer at Keryx Biopharmaceuticals, Inc. from 2003 to 2015.
Mr. Oliviero completed his undergraduate degree at Goizueta Business School-Emory.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/03/2024 | 341,780 ( 0.98% ) | 485 328 $ | 30/04/2024 | |
NUVECTIS PHARMA, INC.
0.16% | 16/06/2023 | 27,828 ( 0.16% ) | 181 160 $ | 30/04/2024 |
James Oliviero active positions
| Companies | Position | Start |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Chief Executive Officer | 13/10/2015 |
| NUVECTIS PHARMA, INC. | Director/Board Member | 01/07/2021 |
Former positions of James Oliviero
| Companies | Position | End |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Director of Finance/CFO | 01/09/2015 |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a private company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Director of Finance/CFO | 01/05/2003 |
Training of James Oliviero
| Goizueta Business School-Emory | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Health Technology |
| NUVECTIS PHARMA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a private company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Health Technology |
- Stock Market
- Insiders
- James Oliviero